Intuitive Surgical, Inc. $ISRG Stock: Leeward Financial Partners LLC Cuts Position

Leeward Financial Partners LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 84.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 526 shares of the medical equipment provider’s stock after selling 2,795 shares during the period. Leeward Financial Partners LLC’s holdings in Intuitive Surgical were worth $214,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Kingswood Wealth Advisors LLC grew its stake in Intuitive Surgical by 15.5% during the third quarter. Kingswood Wealth Advisors LLC now owns 3,720 shares of the medical equipment provider’s stock worth $1,513,000 after buying an additional 498 shares during the period. Sigma Planning Corp raised its stake in shares of Intuitive Surgical by 0.7% in the 3rd quarter. Sigma Planning Corp now owns 7,998 shares of the medical equipment provider’s stock valued at $3,255,000 after acquiring an additional 58 shares during the period. Paladin Wealth LLC raised its stake in shares of Intuitive Surgical by 9.2% in the 3rd quarter. Paladin Wealth LLC now owns 1,338 shares of the medical equipment provider’s stock valued at $544,000 after acquiring an additional 113 shares during the period. Trueblood Wealth Management LLC raised its stake in shares of Intuitive Surgical by 1.7% in the 3rd quarter. Trueblood Wealth Management LLC now owns 1,551 shares of the medical equipment provider’s stock valued at $631,000 after acquiring an additional 26 shares during the period. Finally, Norris Perne & French LLP MI lifted its holdings in shares of Intuitive Surgical by 118.2% during the 3rd quarter. Norris Perne & French LLP MI now owns 2,082 shares of the medical equipment provider’s stock valued at $847,000 after acquiring an additional 1,128 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG opened at $452.29 on Monday. The firm has a market capitalization of $156.78 billion, a P/E ratio of 54.69, a P/E/G ratio of 3.12 and a beta of 1.46. The firm’s 50 day moving average is $395.50 and its 200-day moving average is $408.83. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company posted $2.40 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at $2,016,280. This represents a 6.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the completion of the transaction, the director directly owned 179 shares of the company’s stock, valued at approximately $70,364.90. The trade was a 28.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 12,342 shares of company stock worth $4,882,357. 0.60% of the stock is currently owned by insiders.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Analyst Ratings Changes

ISRG has been the subject of a number of research reports. Royal Bank Of Canada decreased their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research report on Wednesday, October 21st. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research report on Wednesday, October 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Finally, BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.